Loading...

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice

Breast cancers commonly become resistant to EGFR–tyrosine kinase inhibitors (EGFR-TKIs); however, the mechanisms of this resistance remain largely unknown. We hypothesized that resistance may originate, at least in part, from molecular alterations that activate signaling downstream of EGFR. Using a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Lee, Sun-Young, Meier, Roland, Furuta, Saori, Lenburg, Marc E., Kenny, Paraic A., Xu, Ren, Bissell, Mina J.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428077/
https://ncbi.nlm.nih.gov/pubmed/22886303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI60498
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!